[HTML][HTML] Diverse and reprogrammable mechanisms of malignant cell transformation in lymphocytes: pathogenetic insights and translational implications
MA Wasik, PM Kim, R Nejati - Frontiers in Oncology, 2024 - frontiersin.org
While normal B-and T-lymphocytes require antigenic ligands to become activated via their B-
and T-cell receptors (BCR and TCR, respectively), B-and T-cell lymphomas show the broad …
and T-cell receptors (BCR and TCR, respectively), B-and T-cell lymphomas show the broad …
Biological and Clinical Determinants Sha** Heterogeneity in Mantle Cell Lymphoma
C López, E Silkenstedt, M Dreyling, S Beà - Blood Advances, 2024 - Elsevier
Mantle cell lymphoma (MCL) is an uncommon mature B cell lymphoma which presents a
clinical spectrum ranging from indolent to aggressive disease, with challenges in disease …
clinical spectrum ranging from indolent to aggressive disease, with challenges in disease …
[HTML][HTML] BET degrader exhibits lower antiproliferative activity than its inhibitor via EGR1 recruiting septins to promote E2F1-3 transcription in triple-negative breast …
N Liu, S Wang, M Li, N Zhao, D Wang, R Zhang… - Pharmacological …, 2024 - Elsevier
The bromodomain and extraterminal domain (BET) family proteins serve as primary readers
of acetylated lysine residues and play crucial roles in cell proliferation and differentiation …
of acetylated lysine residues and play crucial roles in cell proliferation and differentiation …
Anagrelide and idarubicin combination induces GSDME-mediated pyroptosis as a potential therapy for high-PDE3A acute myeloid leukemia
C Yang, Y Hu, L Gao, Z Li, Y Zhang, R Zhuo, Y Du… - Leukemia, 2024 - nature.com
Acute myeloid leukemia (AML) is an invasive hematopoietic malignancy requiring novel
treatment strategies. In this study, we identified phosphodiesterase 3 A (PDE3A) as a …
treatment strategies. In this study, we identified phosphodiesterase 3 A (PDE3A) as a …
Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma
The use of Bruton tyrosine kinase (BTK) inhibitors such as ibrutinib achieves a remarkable
clinical response in mantle cell lymphoma (MCL). Acquired drug resistance, however, is …
clinical response in mantle cell lymphoma (MCL). Acquired drug resistance, however, is …
A Mitochondria‐Related Signature in Diffuse Large B‐Cell Lymphoma: Prognosis, Immune and Therapeutic Features
ZZ Zhou, JC Lu, SB Guo, XP Tian, HL Li… - Cancer …, 2025 - Wiley Online Library
Background Distinctive heterogeneity characterizes diffuse large B‐cell lymphoma (DLBCL),
one of the most frequent types of non‐Hodgkin's lymphoma. Mitochondria have been …
one of the most frequent types of non‐Hodgkin's lymphoma. Mitochondria have been …
[HTML][HTML] Mitochondrial activity related genes of mast cells identify poor prognosis and metastasis of ovarian cancer
X Ma, C Ligan, S Huang, Y Chen, M Li, Y Cao, W Zhao… - Immunobiology, 2024 - Elsevier
The pro-tumorigenic or anti-tumorigenic role of tumor infiltrating mast cells (TIMs) in tumors
depends not only on the type of cancer and the degree of tumor progression, but also on …
depends not only on the type of cancer and the degree of tumor progression, but also on …
Decreased neurotensin induces ovulatory dysfunction via the NTSR1/ERK/EGR1 axis in polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) is the predominant cause of subfertility in reproductive-
aged women; however, its pathophysiology remains unknown. Neurotensin (NTS) is a …
aged women; however, its pathophysiology remains unknown. Neurotensin (NTS) is a …
[HTML][HTML] EGR1 inhibits clear cell renal cell carcinoma proliferation and metastasis via the MAPK15 pathway
N Peng, Y Cai, D Chen, L Deng, Z Zhang… - Oncology …, 2025 - pmc.ncbi.nlm.nih.gov
Background Clear cell renal carcinoma (ccRCC), the leading histological subtype of RCC,
lacks any targeted therapy options. Although some studies have shown that early growth …
lacks any targeted therapy options. Although some studies have shown that early growth …
EGR1 regulates oral epithelial cell responses to Candida albicans via the EGFR- ERK1/2 pathway
Candida albicans is a fungal pathobiont colonizing mucosal surfaces of the human body,
including the oral cavity. Under certain predisposing conditions, C. albicans invades …
including the oral cavity. Under certain predisposing conditions, C. albicans invades …